Used as a key chiral intermediate in the synthesis of pharmaceuticals, particularly in the development of biologically active compounds targeting central nervous system disorders and metabolic diseases. Its fluorinated pyrrolidine structure enhances metabolic stability and bioavailability, making it valuable in optimizing drug candidates. Commonly employed in the preparation of protease inhibitors and receptor modulators where stereochemistry plays a critical role in efficacy. The hydrochloride salt form improves solubility and handling during synthetic processes.